Get started
Author

K. Filonenko

Observed names: Filonenko, Kateryna, K Filonenko, K S Filonenko, K. S. Filonenko, Kateryna Filonenko
Observed institutions: University of Modena and Reggio Emilia, Epworth Hospital, National Cancer Institute, University Clinical Centre, National Cancer Institute, National Cancer Institute, Children Cancer Hospital, Gdańsk Medical University
ORCID: 0000-0002-0725-3110
Observed ORCID: 0000-0002-0725-3110
OpenAlex ID: A5048770576
T021: Radiation-Free Therapy as the INitial treatment of Good-prognosis early non-bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET-2 - RAFTING Trial.
2022 · Andrea Gallamini, Marco Picardi, et al. · HemaSphere · 6
18F-FDG PET/CT Cannot Substitute Endoscopy in the Staging of Gastrointestinal Involvement in Mantle Cell Lymphoma. A Retrospective Multi-Center Cohort Analysis
2021 · Tetiana Skrypets, Cristina Ferrari, et al. · Journal of Personalized Medicine · 6
PDF
Baseline‐PET derived metrics are the most relevant factors for risk stratification in early‐stage nonbulky HL: preliminary results of the RAFTING trial
2023 · J. M. Zaucha, M. Picardi, et al. · Hematological Oncology · 2
PDF
The predictive value of immunohistochemical expression of Bcl-2, Bcl-6, MUM1, CD10 and CD30 in patients with diffuse large cell lymphoma
2016 · I. Kryachok, A.V. Martynchyk, et al. · Annals of Oncology · 2
PDF
Radiation-free therapy for the initial treatment of good prognosis early non-bulky HL, defined by a low metabolic tumor volume and a negative interim PET after 2 chemotherapy cycles. a phase II prospective rafting trial
2025 · Kateryna Filonenko, Marco Picardi, et al. · Blood · 1
The Low‐risk Early‐stage Hodgkin Lymphoma Patients With Inadequate Response to Chemotherapy. the Preliminary Experience From the Rafting Trial
2023 · K. Filonenko, E. Domingo‐Domenech, et al. · Hematological Oncology · 1
PDF
Subtypes of Malignant Lymphomas in Ukraine, According to 2016 Who Classification. Preliminary Report of the Ukrainian Lymphoma Registry
2021 · T. Skrypets, Y. Stepanishyna, et al. · Hematological Oncology · 1
Implementation and Evaluation of the First Global Blood & Marrow Transplantation (GlobalBMT) Training Program at the University of Illinois at Chicago (UIC)
2019 · Olusola Olowoselu, Ariel Amaru, et al. · Transplantation and Cellular Therapy · 1
Prognostic role of positron emission tomography in patients with primary Hodgkin’s lymphoma
2017 · I. A. Kriachok, O. I. Novosad, et al. · Likarska sprava · 1
PDF
Ukrainian Association for helping patients with lymphoproliferative diseases: Patients support care program
2017 · I. Kryachok, O. Novosad, et al. · Annals of Oncology · 1
PDF
The role of indoleamine 2,3-dioxygenase expression in diffuse large B-cell lymphoma prognosis
2016 · I. Kryachok, T. Skrypets, et al. · Annals of Oncology · 1
Intermediate Results of Treatment of Primary Mediastinal Large В-Cell Lymphoma with Da-Epoch-R Regimen
2014 · I. Stepanishyna, I. Kryachok, et al. · Annals of Oncology · 1
Radiation-Free Therapy for the Initial Treatment of Good Prognosis Early Non-Bulky Hodgkin Lymphoma, Defined by a Low Metabolic Tumor Volume and a Negative Interim PET After 2 Chemotherapy Cycles: The RAFTING Trial Protocol
2026 · Kateryna Filonenko, Marco Picardi, et al. · Biomedicines
Epstein‐Barr Virus‐positive NK/T‐cell Malignancies in Poland: Distinctive Features, Therapeutic Strategies, and Survival Insights—The Real‐world Retrospective Report of the Polish Lymphoma Research Group
2026 · Kateryna Filonenko, Ewa Paszkiewicz‐Kozik, et al. · Asia-Pacific Journal of Clinical Oncology
Post Transplant Lymphoproliferative Disorders: an International Registry Study (the Plato Study)
2025 · NPC Zing, T Skrypets, et al. · Hematology Transfusion and Cell Therapy
884 | the Emotional Burden of Lymphoma: How Lymphoma Survivors Perceive Relationships and Self‐image
2025 · N. Shokun, Y. Stepanishyna, et al. · Hematological Oncology
PDF
743 | Role of Consolidation After Brentuximab Vedotin Treatment in Relapsed/refractory Mycosis Fungoides: Polish Lymphoma Research Group Retrospective Multicenter Study
2025 · E. Chmielowska, K. Filonenko, et al. · Hematological Oncology
PDF
692 | Post Transplant Lymphoproliferative Disorders: an International Registry Study (the Plato Study)
2025 · F. Cavallo, N. Zing, et al. · Hematological Oncology
PDF
417 | TMTV < THAN 32.5 mL IMPAIRS THE SUCCESSFUL DETECTION OF ctDNA IN EARLY‐STAGE HODGIN LYMPHOMA PATIENTS—THE PRELIMINARY REPORT FROM THE RAFTING TRIAL
2025 · M. M. Bednarek, S. Chauvie, et al. · Hematological Oncology
PDF
411 | the Search for Baseline Imaging Predictive Factors of Refractoriness to Abvd in the Low and Very Low Risk Patients With Early Stages Hl of the Rafting Trial
2025 · K. Filonenko, S. Chauvie, et al. · Hematological Oncology
PDF
Efficiency and Safety of Brentuximab Vedotine as a Salvage Treatment Before Autologous Stem Cell Transplantation in Patients With Relapsed or Refractory Classic Hodgkin Lymphoma: Retrospective Study
2025 · Kateryna Filonenko, Yana Stepanishyna, et al. · Advances in Hematology
PDF
Outcome of malignant lymphoma in Ukraine. Analysis of 563 cases registered in the Ukrainian Lymphoma Registry in 2019–2021
2024 · Yana Stepanishyna, Martina Manni, et al. · British Journal of Haematology
P1181: Real-life Treatment Approaches and Therapy Results in the Patients With Primary Mediastinal B-cell Lymphoma: Polish-ukrainian Experience
2023 · Kateryna Filonenko, Agata Szymańska, et al. · HemaSphere
Comparison of the efficiency of peripheral blood stem cell apheresis on the blood cell separators
2022 · Kateryna Filonenko, Veronika Zarutska, et al. · Klinicka onkologie
PDF
Pb2114: Treatment Results in Patients With Diffuse Large B-cell Lymphoma From High-risk Group
2022 · K. Filonenko, I. Kriachok, et al. · HemaSphere
Works count: 49
Citation count: 24
H-index: 2
I10-index:
Year
Topic
Type